Alnylam Pharmaceuticals
ALNY
#549
Rank
NZ$73.96 B
Marketcap
NZ$559.86
Share price
-2.52%
Change (1 day)
15.76%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company